Company intelligence / Profile preview

Ellescope

London, England, United Kingdomellescope.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Ellescope has demonstrated a 62.5% improvement in all self-reported outcomes from antenatal patients during an early feasibility study within NHS primary care, funded by the SBRI Healthcare programme. The company is focused on closing the data intelligence gap in maternity services through its AI-driven digital platform, aiming to improve maternal outcomes and productivity for clinicians.

Therapeutic areas: Women's Health
Modalities: Device (digital health platform)AI-based software solution (data intelligence for maternity care)
Industry: Digital Health Medical Devices

Partnerships

NHS England’s SBRI Healthcare programme (funding partner)Integrated Care Boards, Primary Care Networks, other UK healthcare providers

Beyond the preview

Go deeper on Ellescope.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ellescope.

Explore the full profile